HK Stock Market Move | ALI HEALTH(00241) rose by more than 4%. According to reports, the company's AI product "Hydrogen Ion" has completed its internal testing and is now available for download.

ALI Health (00241) rose by more than 4%, with an increase of 3.78% to HKD 6.86 at the time of writing, with a turnover of HKD 5.32 billion. On the news front, on January 19th, according to Securities Daily, ALI Health's heavyweight AI product "Hydrogen Ion" has completed internal testing and is now available for download. It is understood that the product has entered the practical application stage, mainly targeting doctors in the clinical and scientific research fields. "Hydrogen Ion" emphasizes its core ability of "low illusion, high evidence", with all answers coming from authoritative sources, supporting one-click tracing and direct access to the source, aiming to create the AI assistant with the lowest illusion rate in the medical field. Several doctors who participated in the internal testing provided feedback, stating that "Hydrogen Ion" showed high accuracy in tasks such as evidence-based questioning, evidence integration, and analysis, especially in intelligent retrieval in the context of clinical and scientific research and reading of Chinese and English literature, which is more in line with the habits of domestic doctors. Its product logic is similar to the overseas hit OpenEvidence, but it has a greater advantage in terms of localization experience.